Arxis (NASDAQ:ARXS) Sets New 12-Month Low – Time to Sell?

Arxis, Inc. (NASDAQ:ARXS)’s stock price hit a new 52-week low during mid-day trading on Monday . The company traded as low as $34.25 and last traded at $34.57, with a volume of 15879 shares. The stock had previously closed at $34.59.

Analyst Ratings Changes

A number of analysts recently issued reports on ARXS shares. Rothschild & Co Redburn started coverage on Arxis in a research report on Monday, May 11th. They set a “buy” rating and a $40.00 price objective for the company. Wolfe Research started coverage on Arxis in a research report on Monday, May 11th. They set an “outperform” rating and a $43.00 price objective for the company. Melius Research started coverage on Arxis in a research report on Monday, May 11th. They set a “buy” rating and a $45.00 price objective for the company. Citigroup started coverage on Arxis in a research report on Monday, May 11th. They set a “buy” rating and a $42.00 price objective for the company. Finally, Morgan Stanley started coverage on Arxis in a research report on Monday, May 11th. They set an “overweight” rating and a $44.00 price objective for the company. Ten equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, Arxis has an average rating of “Moderate Buy” and a consensus target price of $45.27.

Arxis Trading Up 0.3%

Insiders Place Their Bets

In other Arxis news, insider Ross Bradley Sealfon bought 12,500 shares of the firm’s stock in a transaction that occurred on Friday, April 17th. The stock was purchased at an average price of $28.00 per share, for a total transaction of $350,000.00. Following the completion of the purchase, the insider directly owned 1,102,807 shares in the company, valued at $30,878,596. This trade represents a 1.15% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Stephen Duane Oetgen bought 25,000 shares of the firm’s stock in a transaction that occurred on Friday, April 17th. The shares were acquired at an average price of $28.00 per share, with a total value of $700,000.00. Following the purchase, the director owned 30,357 shares of the company’s stock, valued at $849,996. The trade was a 466.68% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders have bought 201,564 shares of company stock worth $5,643,792.

Arxis Company Profile

We are a leading designer and manufacturer of proprietary, mission-critical electronic and mechanical components engineered for cutting-edge performance in extreme environments. Leveraging significant intellectual property (“IP”) and world-class engineering capabilities, we design and deliver innovative solutions that address some of our customers’ most complex performance needs. Arxis is the result of a deliberate and disciplined strategy executed by our sponsor, Arcline, and the Arxis management team to create a purpose-built, cohesive business through targeted acquisitions with similar product and end market characteristics.